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The role of Platelet Lysates (PLs) as a source of growth factors (GFs) and as main element of three-
dimensional (3D) hydrogels has been previously described. However, the resulting hydrogels usually suf-
fer from high degree of contraction, limiting their usefulness. This work describes the development of a
stable biomimetic 3D hydrogel structure based on PLs, through the spontaneous assembling of a high
concentration of chitosan-chondroitin sulfate nanoparticles (CH/CS NPs) with PLs loaded by adsorption.
The interactions between the NPs and the lysates resemble the ones observed in the extracellular matrix
(ECM) native environment between glycosaminoglycans and ECM proteins. In vitro release studies were
carried out focusing on the quantiﬁcation of PDGF-BB and TGF-b1 GFs. Human adipose derived stem cells
(hASCs) were entrapped in these 3D hydrogels and cultured in vitro under chondrogenic stimulus, in
order to assess their potential use for cartilage regeneration. Histological, immunohistological and gene
expression analysis demonstrated that the PL-assembled constructs entrapping hASCs exhibited results
similar to the positive control (hASCS cultured in pellets), concerning the levels of collagen II expression
and immunolocalization of collagen type I and II and aggrecan. Moreover, the deposition of new cartilage
ECM was detected by alcian blue and safranin-O positive stainings. This work demonstrates the potential
of PLs to act simultaneously as a source/carrier of GFs and as a 3D structure of support, through the appli-
cation of a ‘‘bottom-up’’ approach involving the assembly of NPs, resulting in an enriched construct for
cartilage regeneration applications.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Cartilage is a predominantly avascular tissue characterized by
sparsely distributed chondrocytes embedded within a dense extra-
cellular matrix (ECM), which is mainly composed of type II col-
lagen and proteoglycans, particularly chondroitin sulfate. Due to
its limited ability to self-repair, cartilage is an ideal candidate for
tissue engineering (TE) [1–5]. During chondrogenic differentiation,
cells prefer a three-dimensional (3D) environment, provided in the
simplest strategy by the cells themselves, referred as ‘‘micromass
pellet culture’’ [3,6] which attempts to mimic the mesenchymal
condensation that happens during embryonic cartilage develop-
ment [2,7]. However in the in vivo scenario, the direct implantationof the cells is usually not enough to obtain a successful defect
regeneration, being required the use of a suitable biomaterial that
acts as a template for cell proliferation and differentiation, provid-
ing also a temporary mechanical support to withstand the tissue
regeneration requirements [3].
Hydrogels can homogeneously encapsulate cells in a 3D
environment with high water content and mechanical properties
reminiscent of cartilage tissue, maintaining a rounded cell mor-
phology which may elicit a chondrocytic phenotype [2,8,9].
Hydrogels based on biopolymers mimic many features of the
ECM and thus have the potential to direct the migration, growth
and organization of cells during tissue regeneration [10]. A wide
range of natural and synthetic polymeric materials have been
investigated as scaffolding for cartilage repair, including alginate
[11,12], agarose [13,14], gelatin [15], hyaluronic acid [16,17], gel-
lan gum [18,19], carrageenan [20,21], and ﬁbrin [22,23], aiming
at supporting the in vitro and in vivo chondrogenic differentiation
of Mesenchymal Stem Cells (MSCs) [2,3].enera-
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interest in cartilage TE as a cell source alternative to autologous
chondrocytes [2,24]. In fact, the number of chondrocytes that can
be isolated primarily from the native cartilage is limited [24] and
they exhibit a very limited proliferation capacity, which draws a
serious limitation to their expansion in culture [25]. Moreover,
the relative instability of their phenotype in cell culture and con-
tinuous dedifferentiation remain a challenge [9,25]. Thus, obtain-
ing multipotent cells which are capable of differentiating toward
the chondrogenic lineage [3] from adult tissues such as bone mar-
row or adipose tissue is currently considered an advantageous pro-
cedure. While bone marrow provides the most universal source of
MSCs, adipose tissue offers a much more abundant and easily
accessible pool of MSCs [26]. Adipose derived stem cells (ASCs)
have been shown to be able to differentiate toward the chondro-
genic lineage in high density micromass cultures, polymeric
scaffolds and hydrogels [2,6,27–29].
The combination of the three fundamental tools, namely cells,
engineering materials and signaling molecules constitutes the triad
of TE aiming to recreate the functional tissue [30]. Growth factors
(GFs) can enhance cartilage formation by different mechanisms,
including through recruitment of chondrogenic cells, enhancement
of cell proliferation and of cartilage matrix synthesis [10]. The use
of platelet concentrates as an alternative approach to the release of
multiple GFs for therapeutic applications is a very exciting area of
research [30]. Platelets contain a wide range of cytokines such as
the isoforms of Insulin Growth Factor (IGF), Platelet DerivedFig. 1. Scheme representing the assembly process of the PL-adsorbed NPs which resu
concentrates obtained from the blood bank were submitted to three temperature shock c
and other bioactive factors; (B) CH/CS NPs were obtained by polyelectrolyte complexatio
to the surface of NPs by mixing both suspensions and further discarding of the non-adsor
together by a centrifugation step, obtaining a hydrogel-like construct with the hASCs en
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others [31]. Platelet derived products are termed Platelet Lysates
(PLs) or Platelet Rich Plasma (PRP) and have been studied and used
since the 1970s [32]. They also have been suggested to possess
impact in the improvement of articular cartilage disorders [3].
Different authors [33,34] have demonstrated that PLs also stimu-
late the proliferation of chondrocytes. However, controversial
results are published on their inﬂuence over the chondrogenic dif-
ferentiation and cartilage matrix accumulation [3,35]. PRP has
been used not only as a cytokine supplement or GF source [36]
but also as the main material to produce 3D scaffolds/hydrogels
[10]. However, their main disadvantage is the increasing instability
and solubility over time, in vitro and in vivo. The hydrogels tend to
considerably shrink, especially when seeded with cells, which
represents an important drawback for application as cell
encapsulation systems [2,37].
In this study we report the development of a novel hydrogel
system based on the assembly of chitosan-chondroitin sulfate
nanoparticles (CH/CS NPs) carrying platelet lysates (PLs). The chi-
tosan/chondroitin sulfate nanoparticles were developed in pre-
vious studies [38], where it was demonstrated that these NPs
were able to support the sustained release of proteins. The design
of the system proposed herein is based on the fact that when used
at high concentrations, the PL-releasing NPs spontaneously assem-
ble in a simple and quick mode to form a 3D hydrogel, capable of
entrapping cells (Fig. 1). Human ASCs (hASCs) were cultured onto
these constructs for up to 28 days and the in vitro chondrogeniclts in a stable construct enabling the entrapment of the hASCs. (A) The platelet
ycles to promote the lysis of the platelets and release their protein content, e.g., GFs
n (PEC) between the two oppositely charged polysaccharides; (C) PLs were adsorbed
bed PLs. (D) PL-loaded NPs and hASCs were mixed in culture medium and assembled
trapped in the network of CH/CS NPs, linked together by the adsorbed PLs.
sate-loaded nanocarriers into enriched 3D hydrogels for cartilage regenera-
V.E. Santo et al. / Acta Biomaterialia xxx (2015) xxx–xxx 3differentiation of the hASCs and possible formation of a
cartilaginous ECM were quantitatively and qualitatively assessed
by various techniques.2. Materials and methods
2.1. Materials
Low molecular weight (116 kDa) chitosan (CH) (Ref: 448869),
chondroitin sulfate (CS) (C9819), phosphate buffered saline tablets
(PBS), Dulbecco’s modiﬁed Eagle’s medium (DMEM) low glucose,
Dulbecco’s modiﬁed Eagle’s medium without phenol red, sodium
bicarbonate and dexamethasone were purchased from Sigma
Aldrich (Germany). Fetal bovine serum (FBS) was purchased from
Biochrom AG (Germany) and antibiotic–antimycotic (A/B)
solution from Gibco (Spain). (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) MTS
reagent was purchased from Promega (G5421, UK). Chitosan was
further puriﬁed by the precipitation procedure, all the other
chemicals were used with no further puriﬁcation. After chitosan
puriﬁcation, the ﬁnal deacetylation degree was 75–85%. ELISA kits
for the detection of human PDGF-BB and TGF-b1 were purchased
from R&D Systems.
2.2. Platelet lysate preparation
PLs were obtained from different platelet collections performed
at Instituto Português do Sangue (IPS, Porto, Portugal), under a pre-
viously established cooperation protocol. The components were
obtained using the Trima Accel Automated Blood Collection
System. All the platelet products were biologically qualiﬁed
according to the portuguese legislation. The platelet count was
performed at the IPS using the COULTER LH 750 Hematology
Analyzer and the sample volume was adjusted to
1 million platelets per lL. The samples were transferred to the lab-
oratory within 24 h after collection and immediately submitted to
three repeated temperature cycles (frozen with liquid nitrogen at
196 C and heated at 37 C) [39], followed by a centrifugation
step at 1400 g for 10 min, to eliminate the platelet debris. The
lysates were then frozen at 20 C until further use. The platelets
remaining were eliminated by centrifugation at 1400 g for 10 min.
2.3. Preparation of the empty and platelet lysate-loaded nanoparticles
Chitosan/chondroitin sulfate nanoparticles (CH/CS NPs) were
prepared as described previously [38]. For further experimental
details, check Supplementary Information (SI). To prepare the
PL-loaded CH/CS NPs, the PLs (mixed from three different donors
to reduce the effect of batch-to-batch variability) were entrapped
by adsorption on the structure to the empty CH/CS NPs, as follows:
approximately 12 mg of empty CH/CS 1/1 NPs was incubated with
5 mL of PLs during 45 min. After that, the particles were allowed to
sediment for 30 min and the excess of PLs was removed. Following
a quick spin-down, the supernatant was discarded and the
PL-loaded NPs were isolated.
2.4. hASC isolation
Human subcutaneous adipose tissue samples were obtained
from elective lipoaspiration procedures performed on women with
ages between 35 and 50 years under a protocol previously estab-
lished with the Department of Plastic Surgery of Hospital da
Prelada in Porto, Portugal. All the samples were processed within
24 h after the lipoaspiration procedure. Human ASCs were
enzymatically isolated from subcutaneous adipose tissue asPlease cite this article in press as: Santo VE et al. Natural assembly of platelet lys
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2.5. Entrapment of hASCs within the assembled PL-loaded NPs
To obtain each sample/construct, approximately 1 mg of PL-
loaded NPs previously prepared as described above, was resus-
pended in 5 mL of DMEM medium. Afterward, the NPs were gently
mixed with 1 million of hASCs suspended in 2 mL of DMEM in
order to obtain a homogeneous dispersion of cells/NPs. The mix-
ture was then centrifuged at 1500 rpm for 10 min and a pellet-like
hydrogel was formed. The same procedure was carried out using
empty NPs, attempting to obtain a similar hydrogel/structure.
Pellets built only with hASCs (1 million cells per construct) were
also prepared to be used as controls. The cell-constructs (with
either empty or PL-loaded NPs) and the hASC pellets were then cul-
tured in vitro in chondrogenic medium composed of DMEM supple-
mented with 1 mM dexamethasone, 0.1 M sodium pyruvate
(P4562 Sigma, Germany), 17 mM L-ascorbic acid (A4544 Sigma,
Germany), 35 mM L-proline (P5607 Sigma, Germany), ITS Liquid
Media Supplement (I2521-insulin-transferrin-selenium-liquid
media supplement, Sigma, Germany), 1% antibiotic and 10% FBS,
for periods 1, 7, 14, 21 and 28 days, in a humidiﬁed atmosphere
at 37 C, containing 5% CO2. The pellet cultures were also
supplemented with 10 ng/mL of TGF-b1. The culture medium
was changed every 3–4 days until the end of the experiment.
2.6. In vitro release studies
Each study sample/construct was formed from approximately
1 mg of PL-loaded NPs resuspended in PBS and centrifuged at
1500 rpm for 10 min to form a pellet-like hydrogel. The same pro-
cedure was applied using empty NPs, attempting to obtain a simi-
lar hydrogel to be used as control. In vitro release studies of GFs
known to be present in signiﬁcant amounts in the PLs, namely
PDGF-BB and TGF-b1, were performed, following the protocol
described in SI.
2.7. Morphological characterization of the constructs – Scanning
Electron Microscopy
The morphology of the assembled NP-PL hydrogels with
entrapped cells was observed by SEM. Energy dispersive spec-
troscopy (EDS) (Pegasus X4 M) was used to perform elemental
analysis on the materials. For further details, check SI.
2.8. Cellular viability assay
Cell viability was assessed after 1, 7, 14, 21 and 28 days, using
the MTS test and the live/dead assay (calcein AM/propidium iodide
(PI) staining). Complete protocols are available as SI.
2.9. Cell proliferation by DNA quantiﬁcation
Human ASC proliferation on the constructs was determined
using a ﬂuorimetric dsDNA quantiﬁcation kit (PicoGreen,
Molecular Probes, Invitrogen, USA), according to the manufac-
turer’s instructions as described in SI.
2.10. Histological analysis
Constructs were harvested at the speciﬁed time points and ﬁxed
with 4% paraformaldehyde. The specimens were included in paraf-
ﬁn and tissue sections of 5 lm of thickness were obtained using a
microtome (Microm HM355S, Thermo Scientiﬁc, Germany), and
mounted in a micro-slide glass.ate-loaded nanocarriers into enriched 3D hydrogels for cartilage regenera-
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were then performed, following standard histological procedures
using the automatic stainer (Microm HMS 740, Thermo Scientiﬁc,
Germany) as described in SI and scored according to the Bern
scoring system [42].
2.11. Immunohistochemistry
Immunostaining for collagen type I, type II and aggrecan
antibodies was performed to assess the formation of cartilagi-
nous-like ECM. Complete protocol is available in SI.
2.12. Real time reverse transcriptase polymerase chain reaction
The expression of mRNA for the genes of interest, usually used
to characterize the chondrogenic phenotype, namely collagen I and
collagen II, was measured by real time RT-PCR analysis. Relative
quantiﬁcation was calculated using 2DDCt method for the
constructs [43]. Experimental details are described in SI.
2.13. Statistical analysis
All the experiments were performed with at least three repli-
cates. The unpaired t-test was used for comparisons between two
groups only. The one-way ANOVA, followed by the Tukey’s post
hoc, was used for comparisons between more than two groups.
p < 0.05 was considered signiﬁcant. Data are shown as
mean ± standard deviation of the means.
3. Results
Fig. 2 displays morphological characterization of the assembled
hydrogels and the release proﬁles of two of the most important GFs
present in the PLs. PDGF-BB and TGF-b1 are some of the isoforms
present in higher concentration in the protein cocktail. Fig. 2A
shows a representative image of the formed hydrogel, with 6 mm
of height. Regarding the release studies, a strong burst effect for
both GFs was observed during the ﬁrst day of delivery, with aFig. 2. (A) Macroscopic view of the hydrogel post-assembly and encapsulating hASCs; (B)
graph represents the cumulative release expressed in total mass of PDGF-BB and TGF-b1
the ﬁrst 24 h is embedded in the ﬁgure. (C) SEM micrographs of the hydrogel resultant fr
two different areas of the hydrogel (## for rough surfaces and # for smooth surfaces); (
including an EDS analysis of speciﬁc elements nitrogen (N) and sulfur at two different r
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the experimental period. In fact, after one day of release, around
2750 pg and 2200 pg of PDGF-BB and TGF-b1 were released and
these account for 92% and 80% of the total release for each GF after
seven days of experiment, respectively. After 7 days, the delivery
was minimal and/or below the detection limit of the ELISA kits.
Assembled PL-loaded NP constructs were prepared with
approximately 4.75 and 4 ng/mL of PDGF-BB and TGF-b1 per
hydrogel, respectively. By comparing these initial protein loadings
with the detected GF release proﬁles, a GF cumulative delivery of
approximately 61% and 70% was attained for PDGF-BB and TGF-
b1, respectively.
Although SEM is not the best technique to characterize the mor-
phological structure of hydrogels, we can observe that PL-loaded
hydrogels presented a more homogeneous surface (Fig. 2C) than
the hydrogels resultant from the assembly of empty NPs
(Fig. 2B). The EDS analysis was performed in different areas of
the material represented in Fig. 2C. At this magniﬁcation, it was
possible to observe differences on the surface topography of the
sample, with smoother surfaces (#) representing cells whereas
the rough sections (##) represent the assembled empty NPs. The
element analysis highlighted this distribution since the sulfur ele-
ment, characteristic of chondroitin sulfate present in the NP com-
plex, is enhanced in the rough surface. PL-loaded hydrogels
(Fig. 2D) are covered with a layer, rich in protein content as indi-
cated by the high nitrogen content region identiﬁed in Fig. 2D by
**. The zone (*) represents a hole in that layer and the EDS analysis
quantiﬁed the inner part of the material. The inner part shows a
signiﬁcant decrease in the nitrogen element (from 11.42 to 7.61
atomic percentage).
Fig. 3 (A–C) shows the results for the live/dead assay performed
in the constructs one day post-encapsulation of hASCs. The assem-
bled hydrogels presented a strong green ﬂuorescent staining which
indicates that the majority of the cells remained viable after the
entrapment process. The hASCs entrapped in the hydrogel enriched
with PLs presented a more elongated and less round shape, thus
showing that the addition of lysate concentrate provides adhesion
points to the embedded cells.In vitro cumulative release of two GFs present in the PLs (PDGF-BB and TGF-b1). The
, quantiﬁed by speciﬁc ELISA kits. The highlighted release proﬁle of both GFs during
om the assembly of empty NPs including an EDS analysis of the sulfur (S) element at
D) SEM micrographs of the hydrogel resultant from the assembly of PL-loaded NPs
egions of the hydrogel (* for inner section of the material and ** for the surface).
sate-loaded nanocarriers into enriched 3D hydrogels for cartilage regenera-
Fig. 3. Assessment of cell viability and proliferation. (A–C) Fluorescent Live/Dead assay image of (A) hASC pellets; (B) empty NP-assembled hydrogel and, (C) assembled PL-
loaded NPs after one day of in vitro culture (scale bar represents 50 lm); (D) MTS viability assay and (E) DNA quantiﬁcation of hASC pellets, NPs and NP-PL constructs with
hASCs cultured in vitro up to 28 days. Results are expressed as mean ± standard deviation with n = 3 for each bar. * indicates statistically signiﬁcant differences (p < 0.05) and
# indicates statistically signiﬁcant differences between the conditions at that speciﬁc culture period and day 1 of culture (p < 0.05).
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results obtained show that cells were able to remain viable in
the constructs during the 28 days of experiment, although signiﬁ-
cant differences between the different formulations could be
detected, as shown in Fig. 3D. After 7 days of culture, we could
observe a statistically signiﬁcant enhancement of total cell viabil-
ity for all formulations. This may be consequence of two factors:
either the cells were proliferating and thereby more MTS was
metabolized or the proliferation rates were not that high but
the mitochondrial machinery was highly active, converting higher
amounts of MTS. Fig. 3E shows that after day 7, there was a
signiﬁcant increase in cell proliferation when compared to day
1. The micromass cultures of hASCs displayed a similar cell
proliferation to the PL-loaded hydrogel at day 7, however their
viability was signiﬁcantly lower (p < 0.05). The viability of the
hASCs entrapped in the PL-loaded CH/CS assembled NP mesh
was always higher in comparison with the controls despite the
similar proliferation rate. Cell proliferation occurred mostly
during the ﬁrst week and remained relatively stable throughout
the culture period (Fig. 3E).
In Fig. 4, the H&E stained sections allowed the visualization of
the cell distribution in the constructs. At early culture time points
(e.g., day 7), cells at the peripheral region of the construct were
ﬂattened and aligned along the surface whereas cells exhibited a
round morphology toward the center. While the pellet controls
showed a homogeneous cell distribution during all culture periods,
the hydrogels resultant from the assembly of NPs presented a pro-
gressive improvement in this speciﬁc feature. The intense red
staining detected the hydrogel materials (PL-loaded or empty
NPs), which was stronger at day 7 and 14 (Fig. 4B) than in the
remaining time points because the NP core was still not strongly
invaded by cells and newly deposited ECM. At the early stage of
culture, the cells surrounded a core of NPs but their integration
within the matrix progressed and increased with time.Please cite this article in press as: Santo VE et al. Natural assembly of platelet lys
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between cells and the materials in comparison with the hydrogel
prepared with empty NPs (Fig. 4A and B). In fact, the hydrogel
formed by the assembly of empty NPs gradually lost its stability,
shape and dimensions, which led to cell loss from the construct
(particularly after histological processing), as it is clear in Fig. 4B.
On the contrary, a better integration of the cells in the PL-loaded
hydrogel matrix was evident (Fig. 4A). On the other hand, the
micromass culture presented the typical dense structure with cells
embedded in a newly synthesized dense ECM (Fig. 4C). Although
the initial cell number was the same for the control formulation,
the hASC pellet sample size was always considerably smaller than
the tested hydrogels and their size did not change drastically over
time.
Fig. 5 depicts different read-outs for the assessment of chondro-
genic differentiation of hASCs in each tested condition, as well as
the deposition of cartilage-like ECM. The PL-loaded NP hydrogel
resulted in a more homogeneous and intense alcian blue and safra-
nin-O stainings (Fig. 5A) throughout the construct, with a more
even distribution of cartilage ECM when compared with the empty
NP assembled hydrogel (Fig. 5A). The hASC pellets present a more
intense staining for both alcian blue and safranin-O (Fig. 5A) when
compared with the other hydrogels, especially at day 14. This
intense staining can also be explained by the smaller size of the
construct, and thus higher concentration of cells and ECM in a
smaller area. In the case of the empty NP-assembled hydrogel, it
is clear that the structure lost the stability with time, which led
to cell loss and lower ECM formation, conﬁrming the data obtained
with H&E staining.
The results previously presented in the histological analysis ﬁnd
some reﬂection on the Bern Score semi-quantitative analysis
(Fig. 5B). Among the studied formulations, the control pellets
exhibited the best results in terms of quality of the newly formed
tissue. The scores at day 14 and 28 show a slightly positiveate-loaded nanocarriers into enriched 3D hydrogels for cartilage regenera-
Fig. 4. Light microscopy images of histological sections obtained from hASCs encapsulated in the assembled PL-NP hydrogels (A), NP hydrogels (B) and pellets (C), and stained
for H&E, after 14, 21 and 28 days of culture in chondrogenic medium.
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relevant variations were encountered and despite the positive
evaluation, these constructs were always ranked worse regarding
the quality and performance of the newly formed tissue when
compared to the pellet control. Pellet controls showed a slight
decrease in the quality scores between days 14 and 28 of culture.
In particular, scores for the micromass cultures peaked at day 14,
presenting statistically signiﬁcant differences (p < 0.05) to all the
remaining formulations and decreasing at day 28. This can be
explained by the material loss (both cellular and ECM) during the
last 14 days of culture. The PL-loaded hydrogels always showed
statistically signiﬁcant differences (p < 0.05) to the assembled
empty NP hydrogel, once again proving the importance of the
adsorption of PLs to the NPs for the success of the developed
construct.
The new ECM formation was also characterized by the
immunolocalization of collagen type I and II and aggrecan as
observed in Fig. 5A. Immunohistological analysis revealed the
positive staining for both collagen type II and type I (Fig. 5A)
in the newly formed cartilage-like matrix, for the PL-loaded
hydrogel and the pellet control. Collagen II expression was par-
ticularly intense in the pellets, conﬁrming the histological obser-
vation. Collagen II in the PL-loaded hydrogel was more clearly
detected on the outer layers of the construct after 14 days of cul-
ture (Fig. 5A) and spread toward the core of the hydrogel until
day 28. In Fig. 5A, we can also observe the accumulation of
aggrecan mostly on the hASC pellets but also, although with less
intensity, in the PL-loaded hydrogel. The hydrogels formed from
the assembly of empty NPs only showed residual areas of
collagen I and II (Fig. 5A) positive staining. The progressive cell
loss from these non-loaded constructs is a limiting factor for
the further success of these materials. For the empty NP hydro-
gel, the accumulation of aggrecan in the 3D structure was also
reduced.Please cite this article in press as: Santo VE et al. Natural assembly of platelet ly
tion. Acta Biomater (2015), http://dx.doi.org/10.1016/j.actbio.2015.03.015Due to the lack of gel stability and severe cell loss during the
experiment, the evaluation of gene expression was not studied
for the NP-assembled control.
The level of collagen type II expression for the PL-loaded NP
hydrogel and for the hASCs pellets was upregulated throughout
the experiment and it gradually increased over time, as it can be
observed in Fig. 5C. The pellets always presented average higher
upregulations of collagen type II when compared with the PL-
loaded hydrogel. However, no statistically signiﬁcant difference
(p < 0.05) between both study groups was detected. In the case of
collagen type I expression (Fig. 5D), PL-enriched hydrogel
expressed collagen I in higher levels than hASC pellets (with sta-
tistically signiﬁcant differences (p < 0.05)). Despite the stronger
upregulation of collagen type I observed in the PL-loaded hydrogel,
the upregulation level of the gene does not go further than the
3-fold increase, while for collagen type II expression, values
reached around 40-fold increase after 28 days of culture.4. Discussion
Cartilage can be classiﬁed as a self-assembled tissue structure
organized at different nano-, micro- and macro-scale levels [9].
The design criteria for the development of a bottom-up hydrogel
must begin with proto-units of the nanomaterial assembled into
higher order structures incorporating either chondrocytes or
stem/progenitor cells, with appropriate signals for morphogenesis
of cartilage [9].
The rationale behind this study (Fig. 1) followed a bottom-up
approach as the hydrogels are developed from the assembly of
NPs loaded with a protein cocktail that allows their stabilization
and organization in a 3D structure, while it is simultaneously
capable of entrapping hASCs. The process of tissue growth and
development requires a constant supply of instructive cues andsate-loaded nanocarriers into enriched 3D hydrogels for cartilage regenera-
Fig. 5. Assessment of chondrogenic differentiation of hASCs in the assembled constructs. (A) Light microscopy images from histological and immunohistochemical evaluation
of the constructs collected at day 14 and 28 of in vitro culture under chondrogenic stimulus; (B) Bern scoring system performed by 5 independent users based on the safranin-
O staining. (*) represents a statistically signiﬁcant difference (p < 0.05) between the pellets and the remaining formulations, (**) represents statistically signiﬁcant differences
(p < 0.05) between the pellets and the empty NP-assembled hydrogel and (***) represents statistically signiﬁcant differences (p < 0.05) between PL-loaded NP hydrogel and
empty NP loaded hydrogel; (C and D) Relative gene expression of collagen type II (C) and collagen type I (D) in hASCs encapsulated in the assembled hydrogels. The expression
of these genes was normalized against the housekeeping gene GAPDH and calculated by the Livak method (2DDCt). Results are expressed as average ± standard deviation
with n = 3 for each bar. (*) indicates a statistically signiﬁcant difference (p < 0.05) between the PL-loaded NP hydrogel and the hASC pellets.
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GFs and bioactive proteins from PL concentrate (Fig. 1A). The poly-
electrolyte complexation between two oppositely charged polysac-
charides – chitosan and chondroitin sulfate, resulted in the
formation of NPs, that besides the carrier and release function,
are also able to induce the assembling of the NP-PLs into a 3D sup-
port for cartilage TE (Fig. 1B). In their native biological contexts,
many polysaccharides are found organized at the nanoscale into
complex assemblies such as the aggrecan aggregate in mammalian
tissues [44]. Chitosan is the partially deacetylated form of chitinPlease cite this article in press as: Santo VE et al. Natural assembly of platelet lys
tion. Acta Biomater (2015), http://dx.doi.org/10.1016/j.actbio.2015.03.015featuring a variable number of randomly located N-acetyl-glu-
cosamine groups. These groups are also found in various GAGs pre-
sent in articular cartilage, having speciﬁc interactions with many
GFs, adhesion proteins and receptors [10]. Chondroitin sulfate is
a sulfated GAG with reported beneﬁciary aspects in preventing
the prevalence of osteoarthritis, namely on the prevention of pro-
teoglycan degradation in the osteoarthritis model in rabbit and
anti-inﬂammatory properties [10]. The presence of chondroitin
sulfate has also been shown to enhance the expression of collagen
type II in 3D cultures of chondrocytes [10] and to bind theate-loaded nanocarriers into enriched 3D hydrogels for cartilage regenera-
8 V.E. Santo et al. / Acta Biomaterialia xxx (2015) xxx–xxximportant ﬁbrillar forms of collagen I and II [44]. Due to the role of
chitosan and chondroitin sulfate in cartilage tissue, the CH/CS com-
plex may exhibit beneﬁcial features for cartilage regeneration and
recreation of the environment of ECM and thus it seemed an appro-
priate selection for scaffolding material. Controlled GF delivery sys-
tems should be designed to deliver multiple soluble proteins at
different rates to accelerate and enhance tissue regeneration
[30,45]. These GFs can be immobilized in a matrix through physical
adsorption (Fig. 1C), which involves the formation of ionic com-
plexes or electrostatic interactions between oppositely charged
groups on GFs and polymer chains on the substrate [46].
In this study, the cell-signaling molecules were incorporated
into the bulk of the constructs and not only on the surface
(Fig. 1D). The native ECM shows the ability to speciﬁcally store
and sequester GFs and this feature has been emulated by this strat-
egy [47]. In fact, the strategy herein described also promotes the
positioning of functional motifs close to cell membrane receptors
[48].
The observed burst release effect in the assembled construct
(described in Fig. 2) was expected as the immobilization of pro-
teins to the carriers through physical adsorption typically is usu-
ally characterized by less controlled release proﬁles [46].
However, in this strategy the lysates were used not only as bioac-
tive agent source to promote cell proliferation and differentiation
but also as a material to establish links between the NPs, in order
to form the assembled hydrogel. The stability of the construct
throughout the culture period suggests that the fast release of
GFs loosely linked to the NPs during the ﬁrst 7 days was not pro-
longed for the remaining culture period. The proteins and GFs pre-
sent in the construct did not deadsorb as easily possibly because
meanwhile hASCs also started to deposit cartilaginous ECM, creat-
ing a more compact and dense material.
The combination of results from viability and proliferation
assessment suggests that cell pellets and PL-loaded hydrogels pre-
sented similar levels of cell proliferation, with the former display-
ing lower levels of cell viability. The availability of bioactive factors
from PL dispersed in the hydrogel overcomes some of the diffusion
issues associated with pellet cultures, therefore contributing for an
overall higher cell viability of the hASCs entrapped in these con-
structs. Moreover, more than providing bioactive molecules for cell
proliferation and differentiation, PLs also acted on the physical
stabilization of the hydrogel, creating a more appropriate 3D
environment for hASC survival.
PLs have also been indicated in the literature as inducers of cell
proliferation but this fact was not evident in these studies [33,49].
However, as observed by the GF release proﬁle, the delivery of
bioactive agents occurred mostly during the ﬁrst 7 days, more
speciﬁcally at day 1. The release proﬁle matched the cell prolifera-
tion pattern because the latter was more evident precisely during
the ﬁrst 7 days of culture. The lack of signiﬁcant cell proliferation
in the remaining time points of the experiment might also indicate
that hASCs were undergoing chondrogenic differentiation. The
three formulations showed similar proliferation kinetics through-
out most of the experiment. The similar cell proliferation proﬁle
exhibited by the PL-loaded NP hydrogel and the control pellet cul-
tures might be explained by the structural environment in which
the cells are cultured. In fact, even though when the cells are cul-
tured in the presence of the PL-rich environment they have access
to additional proteins, hASC pellets are exposed to the culture
medium with a higher surface area and do not have a material
barrier to delay their nutrient exchanges [29].
The H&E stainings revealed that the cells entrapped in the
hydrogel assembled from the PL-loaded NPs were progressively
migrating toward the core of the hydrogel. PL-rich NPs acted as
an attractant agent for the cells and the deadsorption of some of
the PLs from the CH/CS NPs led to bigger pores and gaps in thePlease cite this article in press as: Santo VE et al. Natural assembly of platelet ly
tion. Acta Biomater (2015), http://dx.doi.org/10.1016/j.actbio.2015.03.0153D structure, allowing cell inﬁltration and consequently better
integration of the entrapped cells with the material. The constructs
obtained from the empty NPs entrapping hASCs showed lower sta-
bility and the hydrogel disintegrated more easily, clearly demon-
strating that the PLs are important not only for the release of
GFs, but also for creating a stable 3D matrix.
Previous studies found in the literature concerning the use of
hydrogels based only on PRP, mostly report the activation with
bovine thrombin and crosslinking with calcium [50,51]. Despite
the potential of those systems, the contraction observed in most
of them during the culture period results in an ineffective strategy.
The hydrogels quickly lose their shape and dimensions and conse-
quently the construct disintegrates and becomes dispersed within
the defect area. Herein, it is shown the multifunctional role of PLs,
which enable the maintenance of the structure of the ‘‘biomaterial’’
through the combination of the lysates with a polysaccharide-
based hydrogel, which resulted in a more stable formulation,
closely mimicking the native ECM.
The results from cell proliferation and histological assessment
suggest that the evolution of the tissue engineered cartilage con-
structs with culturing time progressed in two stages. The ﬁrst
one consisted of a cell growth phase characterized by increased cell
proliferation until up to 7 days. The second stage can be described
as a cell differentiation and tissue growth stage, which was
characterized by decreased proliferation and increased collagen
and proteoglycan deposition.
Histological score systems are frequently used to grade the
healing process and tissue quality of cartilage defects. These
semi-quantitative systems provide reliable information on the
pathophysiological condition of the tissue being investigated and
have good reproducibility. Among the various scoring systems pro-
posed, the Bern score is considered to be one of the most reliable
for evaluation of cartilage formation in vitro [52]. This semi-
quantitative analysis conﬁrmed that the PL-loaded hydrogels
contributed for the deposition of cartilage-like ECM and that their
performance was statistically signiﬁcantly improved when com-
pared with the non-loaded NP-assembled hydrogel.
Collagen type II is responsible for the tensile properties of carti-
lage tissue, forming a dense network of ﬁbers responsible for
retaining the aggrecan during compressive loading [7] and it is
the most important protein produced by chondrocytes. Although
collagen type I is not found in mature hyaline cartilage ECM, it
may play vital roles regulating both in mesenchymal condensation
and chondrogenic differentiation [7]. Mesenchymal progenitor
cells can secrete an ECM rich in collagen type I before the onset
of overt chondrogenesis. However, as overt chondrogenesis begins
and the expression of mature cartilage matrix molecules starts, the
production of collagen type I stops [7]. Both collagen II and I were
upregulated for the PL-loaded hydrogel, however the enhanced
expression was signiﬁcantly higher for collagen II, thus suggesting
the formation of new hyaline-type cartilage tissue rather than
ﬁbrous cartilage. The differentiation of hASCs toward the chondro-
genic phenotype was an ongoing process and a complete mature
chondrocyte phenotype had not yet been settled. Both the
histological and gene expression conﬁrmed that chondrogenic dif-
ferentiation was higher for the hASC pellets positive controls,
which can be explained by the supplementation with TGF-b1 in
the culture medium.
In this study, the role of PLs as a source of bioactive agents to
promote enhancement of chondrogenic differentiation was lim-
ited. Although PLs contain TGF-b1, that plays a key role in the reg-
ulation of cellular proliferation, differentiation and cartilage matrix
formation [4,8,25,27] and can exhibit differential effects depending
on the differentiation stage of the target cells [53], the chondro-
genic differentiation was not clearly enhanced when compared
with the control formulation. These ﬁndings might be explainedsate-loaded nanocarriers into enriched 3D hydrogels for cartilage regenera-
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and by the initial loading of TGF-b1 in the PL-loaded hydrogels to
be approximately 4 ng per construct. This value is well below the
standardized TGF-b1-supplemented chondrogenic medium used
for the pellet cultures in our positive controls.
On the other hand, the structural role of the lysates as a decisive
component of this ‘‘bottom-up’’ design of the hydrogel is the major
outcome of this strategy. PLs acted as a raw material to promote
the connections and links to the NPs, in order to fabricate a hydro-
gel mesh for the entrapment of stem cells that will be able to better
withstand the in vivo environment conditions than the hydrogel
resultant from the assembly of empty NPs or the cell pellets. The
design of the system aims for an injectable minimally invasive
approach, providing an advantage over the injection of cell suspen-
sions, which lack structural support and will eventually diffuse out
of the injection site. The combination of PL-loaded NPs with hASCs
will avoid the migration of cells toward undesired locations while
simultaneously acquiring the shape of the defect and providing an
additional template for mechanical support at the injection site.
Moreover, the dynamic interplay between cells and the cartilage
ECMmolecules, such as chondroitin sulfate, is a contributing factor
to the beneﬁcial effect of the ECM-mimicking hydrogel that we
propose in this study, since the environmental context is very simi-
lar to the native cartilage tissue [54].5. Conclusion
This study showed that it was possible to use PLs
simultaneously as a source and carrier of GFs, assembling both
functionalities into a 3D structural support through a ‘‘bottom-
up’’ approach. This approach uses the assembly of NPs, promoted
by the adsorption of PLs to the surface of the NPs and allowed over-
coming the usual contraction effect found in PL based hydrogels.
Furthermore, the proposed methodology enabled the development
of an innovative system that provides an adequate environment for
the encapsulation of hASCs, through the enrichment with the GFs
released from the PLs.
Furthermore, the use of the complex CH/CS as one of the com-
ponents of the matrix, in the NP formulations, is also appropriate
for the development of constructs for cartilage regeneration
because the interactions between chondroitin sulfate, one of the
most important GAGs in ECM, and the proteins, present in the
PLs cocktail, mimic the in situ environment of cartilage ECM.
In summary, this study demonstrated that PLs can work not
only as a GF supplement for cell proliferation and differentiation
but can also provide stability of a support structure, through the
entanglement of the protein chains with the CH/CS NPs, assembled
into a 3D hydrogel. It is envisioned the translation of this system
into the clinic by the isolation of autologous blood in-theater with
follow-up combination with hASCs from the same patient and CH/
CS NPs to produce and injectable biomaterial for cartilage
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